Governance Neurotech International Limited
Equities
NTI
AU000000NTI9
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0140 AUD | 0.00% |
|
-6.67% | - |
| Dec. 16 | Neurotech International receives A$4 million placement commitments | RE |
| Dec. 14 | Neurotech International requests trading halt pending capital raising announcement | RE |
Executive Committee: Neurotech International Limited
| Manager | Positions heldSince | ||
|---|---|---|---|
![Anthony Filippis](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>) Anthony Filippis |
| ||
Alexandra Andrews |
| ||
Alessandra Gauvin |
|
Composition of the Board of Directors: Neurotech International Limited
| Director | CommitteesSince | ||
|---|---|---|---|
Mark Davies |
| ||
Robert Johnston |
| ||
Anthony Filippis |
| ||
Gerald Quigley |
|
Latest Appointments: Neurotech International Limited
Former Officers and Directors: Neurotech International Limited
| Insider | Positions held SinceUntil | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
| |||||||||
|
| |||||||||
|
| |||||||||
|
| |||||||||
|
| |||||||||
|
| |||||||||
|
| |||||||||
|
| |||||||||
|
| |||||||||
|
| |||||||||
|
| |||||||||
|
| |||||||||
|
| |||||||||
|
| |||||||||
|
| |||||||||
|
| |||||||||
|
| |||||||||
|
| |||||||||
|
|
Age distribution of managers
Parity Men Women
| Male | 5 |
|---|---|
| Female | 1 |
Of which Executive Committee
| Male | 2 |
|---|---|
| Female | 1 |
Of which Directors
| Male | 4 |
|---|---|
| Female | 0 |
Departures of Key Persons
Chairman
2020-10-18 2022-08-15
Chief Executive Officer
2022-03-07 -
Chief Executive Officer
2018-11-25 2020-10-18
Chairman
2016-01-14 2019-04-15
Chief Executive Officer
2016-05-11 2018-11-23
Select your edition
All financial news and data tailored to specific country editions
